{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T04:28:49Z","timestamp":1689049729486},"reference-count":10,"publisher":"Academy of Medicine, Singapore","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Acad Med Singap"],"published-print":{"date-parts":[[2023,6,27]]},"abstract":"<jats:p>Stroke prevention in patients with atrial fibrillation (AF) using anticoagulants involves weighing the benefits of reduced ischemic stroke1,2 against the elevated risks of serious bleeding events.3 Warfarin and direct oral anticoagulants (DOACs) are the available oral anticoagulants for this indication.<\/jats:p>","DOI":"10.47102\/annals-acadmedsg.2022437","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T03:31:46Z","timestamp":1688959906000},"page":"324-326","source":"Crossref","is-referenced-by-count":0,"title":["Preferences for oral anticoagulant medications for managing atrial fibrillation"],"prefix":"10.47102","volume":"52","author":[{"given":"Yu Zhi","family":"Pang","sequence":"first","affiliation":[{"name":"National Neuroscience Institute, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deidre Anne","family":"De Silva","sequence":"additional","affiliation":[{"name":"National Neuroscience Institute, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Ng","sequence":"additional","affiliation":[{"name":"Duke-NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinh Anh","family":"Huynh","sequence":"additional","affiliation":[{"name":"Duke-NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Ozdemir","sequence":"additional","affiliation":[{"name":"Duke-NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"26165","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92.","DOI":"10.1517\/13543784.2012.696611"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.","DOI":"10.1517\/14656560903530691"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Wilke T, Bauer S, Mueller S, et al. Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review. Patient 2017;10:17-37.","DOI":"10.1007\/s40271-016-0185-9"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Wang Y, Wang Z, Wang Z, et al. Application of Discrete Choice Experiment in Health Care: A Bibliometric Analysis. Front Public Health 2021;9:673698.","DOI":"10.3389\/fpubh.2021.673698"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91.","DOI":"10.1056\/NEJMoa1009638"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Diener HC, Connolly SJ, Ezekowitz MD, et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol 2010;9:1157-63.","DOI":"10.1016\/s1474-4422(10)70274-x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.","DOI":"10.1001\/jama.285.22.2864"},{"key":"ref7","unstructured":"Johnson R and Orme B. Getting the most from CBC. Sawtooth Software. Research paper series, 2003. https:\/\/sawtoothsoftware.com\/resources\/technical-papers\/getting-the-most-from-cbc. Accessed 8 June 2022."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Gonzalez JM. A Guide to Measuring and Interpreting Attribute Importance. Patient 2019;12:287-95.","DOI":"10.1007\/s40271-019-00360-3"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Okumura K, Inoue H, Yasaka M, et al. Japanese Patients\u2019 and Physicians\u2019 Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment. JHEOR 2015;2:207-20.","DOI":"10.36469\/9904"}],"container-title":["Annals of the Academy of Medicine, Singapore"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T06:45:09Z","timestamp":1688971509000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals.edu.sg\/preferences-for-oral-anticoagulant-medications-for-managing-atrial-fibrillation\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,27]]},"published-print":{"date-parts":[[2023,6,27]]}},"URL":"https:\/\/doi.org\/10.47102\/annals-acadmedsg.2022437","relation":{},"ISSN":["0304-4602"],"issn-type":[{"value":"0304-4602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}